UNSPSC 51392204: Coumazoline

This classification denotes an alpha-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TR7Y641235. European Medicines Agency schedules Coumazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06815MIG. Coumazoline generally arises in the molecular formula C14H16N2O.

UNSPSC 51392204 Coumazoline is a Commodity code that appears in state and local procurement records with minimal recent activity directly aligned to the code's nominal scope. The single recent opportunity tagged under this code—Seminole County, Florida's IFB60459723LAS—actually solicits naloxone and safe drug deactivation systems for community health support, not coumazoline. Seminole County, a county government in central Florida, posted this IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building. The mismatch between the code designation and the actual procurement scope suggests either a classification error in the issuing body's tagging or a shift in how the code is being applied in practice; the opportunity itself falls outside the chemical anticoagulant product category the code nominally describes.

The response deadline for the Seminole County IFB was July 26, 2023, with bidders required to submit electronically through the county's e-Procurement Portal and include all shipping and delivery costs. Vendors must meet E-Verify compliance, drug-free workplace certification, and specified insurance requirements. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary period. Beyond this single opportunity, the source provides no additional recent state and local solicitations tagged to UNSPSC 51392204, indicating minimal market activity under this code in the tracked state and local procurement universe as of late 2026.